![Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial - The Lancet Oncology Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/c9cb4868-a7f2-4dfd-b0d4-fc0eaf6213fa/gr2_lrg.jpg)
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial - The Lancet Oncology
![Healthcare | Free Full-Text | Ultrasound in the Differential Diagnosis of Medial Epicondylalgia and Medial Elbow Pain—Imaging Findings and Narrative Literature Review Healthcare | Free Full-Text | Ultrasound in the Differential Diagnosis of Medial Epicondylalgia and Medial Elbow Pain—Imaging Findings and Narrative Literature Review](https://www.mdpi.com/healthcare/healthcare-10-01529/article_deploy/html/images/healthcare-10-01529-g001.png)
Healthcare | Free Full-Text | Ultrasound in the Differential Diagnosis of Medial Epicondylalgia and Medial Elbow Pain—Imaging Findings and Narrative Literature Review
![Clinical and surgical anatomy of the liver: A review for clinicians - Juza - 2014 - Clinical Anatomy - Wiley Online Library Clinical and surgical anatomy of the liver: A review for clinicians - Juza - 2014 - Clinical Anatomy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aa61471e-2b74-47d5-b787-f948c8fd36e1/ca22350-fig-0005-m.jpg)
Clinical and surgical anatomy of the liver: A review for clinicians - Juza - 2014 - Clinical Anatomy - Wiley Online Library
![Cureus | Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment | Article Cureus | Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment | Article](https://assets.cureus.com/uploads/figure/file/680568/article_river_4e35b7601c6211eebab65f827f5ef98e-Psoriasis-Figure-.png)
Cureus | Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment | Article
![Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis](https://pubs.acs.org/cms/10.1021/acs.jproteome.3c00463/asset/images/medium/pr3c00463_0006.gif)
Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis
![Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level - The Lancet Rheumatology Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/c723c075-606e-4796-8f60-a82d641df804/gr1_lrg.jpg)
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level - The Lancet Rheumatology
![IJMS | Free Full-Text | State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer IJMS | Free Full-Text | State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer](https://pub.mdpi-res.com/ijms/ijms-23-03470/article_deploy/html/images/ijms-23-03470-g004.png?1648023189)